- Analysis - SpaceX-Tesla Merger: Musk Gains Voting Control, but No Trillion-Dollar Compensation
- The US Dollar Index rises in tandem with oil prices as geopolitical news stirs the market.
- Saudi Aramco expands the east-west oil pipeline to bypass the Strait of Hormuz
- Frequent Ship Attacks in the Strait of Hormuz Sustain High Volatility in the Energy Market
- CLOUDFLARE <NET.N>: JP MORGAN RAISES TO OVERWEIGHT FROM NEUTRAL
- BeOne Medicines Presents at Jefferies Global Healthcare Conference
- Buenaventura announces interim dividend of $0.5508 per share
- Global Payments Sets 1% Ownership Threshold for Shareholder Derivative Suits
- Spark Energy Minerals Defines 21.3-Square-Kilometer Rare Earth Target at Boa Vista
- Clarivate Q3 2026 net loss more than doubles to $80.8 million
- Henry Schein Q3 GAAP diluted EPS rises 26% to $1.06
- Aimei Health Removes United Hydrogen Reference From Promissory Note Disclosure
- Ceragon Partners With RADWIN to Expand Sub-6 GHz Wireless Portfolio
- ADM 3Q26 net earnings rise to $821 million
- Rockwell Medical Withdraws 2026 Financial Guidance on Expected Acquisition Costs
- Tevogen Extends $36 Million Credit Facility With Patel Family to May 2029
- Del Monte Participates in Stephens Annual Investment Conference
- Osisko Metals Intersects 314 Meters Averaging 0.44% Copper at Gaspé Project
- Enlight Q3 net income rises to USD 33.52 million; Q3 revenues and income climb 40% year over year to USD 231.37 million
- Elemental Royalty Publishes Update to Financial Calendar
- Onar Holding Files Draft Information Statement
- TNL Mediagene Appoints Shing Hei Lee to Board
- Rockwell Medical agrees to buy Vantive’s hemodialysis assets for $125 million
- Clarivate Sees 4Q Rev $490M-$510M >CLVT
- Clarivate Sees 2025 Rev $1.97B-$1.99B >CLVT
- Archer Daniels Midland Cutes 2026 Capital Spending View to $1.2B-$1.3B From $1.3B-$1.5B >ADM
- Louisiana-Pacific Q3 net income more than doubles to $23 million
- Gartner Q3 2026 net income rises to $214.4 million year over year
- Fortis Q3 Net Earnings Rise 16% to CAD 474 Million
- BRIEF-Leidos Q3 Adjusted EPS USD 3.62 Vs. IBES Estimate USD 3.03
- BRIEF-Amneal Pharmaceuticals Q3 Revenue USD 863 Million Vs. IBES Estimate USD 815.9 Million
- BRIEF-Ball Q3 Adjusted EPS USD 1.1 Vs. IBES Estimate USD 1.07
- BRIEF-ADM Q3 Adjusted EPS USD 1.77 Vs. IBES Estimate USD 1.6
- BRIEF-Fortis Q3 Adjusted EPS CAD 0.92 Vs. IBES Estimate CAD 0.88
- BRIEF-Dupont De Nemours Inc Q3 Adjusted EPS USD 2.09 Vs. IBES Estimate USD 1.87
- BRIEF-Louisiana-Pacific Q3 Adjusted EBITDA USD 82 Million Vs. IBES Estimate USD 63.8 Million
- BRIEF-Gartner Q3 Adjusted EPS USD 3.59 Vs. IBES Estimate USD 2.84
- BRIEF-Henry Schein Q3 Adjusted EPS USD 1.56 Vs. IBES Estimate USD 1.36
- BRIEF-Revvity Q3 Adjusted EPS USD 1.37 Vs. IBES Estimate USD 1.3
- Rockwell Medical: Transaction Is Expected to Close Mid-2027 >RMTI
- BRIEF-Waters Q3 Adjusted EPS USD 4.1 Vs. IBES Estimate USD 4
- Rockwell Medical Will Acquire Vantive's State-Of-The Art One M Square Foot Manufacturing Campus in Medolla, Italy >RMTI
- IDEAYA Biosciences 3Q Loss/Shr $1.22 >IDYA
- IDEAYA Biosciences 3Q Rev $10.2M >IDYA
- Rockwell Medical Estimates That the Combined Business Could Generate Annual Rev Between $400M and $450M >RMTI
- Archer Daniels Midland Had Seen 2026 Adjusted EPS $5.15-$5.60 >ADM
- Archer Daniels Midland Raises 2026 View To Adj EPS $5.50-Adj EPS $5.80 >ADM
- Cell C directors, company secretary accept options worth R 20.86 million
- Wise Group Announces Annual General Meeting
- Revvity 3Q Adj EPS $1.38 >RVTY
- Waters Corp 3Q Rev $1.77B >WAT
- Waters Corp 3Q Adj EPS $4.10 >WAT
- Waters Corp 3Q EPS 82c >WAT
- Henry Schein 3Q Adj EPS $1.56 >HSIC
- Fortis Inc 3Q EPS C$0.92 >FTS
- DuPont de Nemours 3Q Organic Sales Growth Up 5% >DD
- DuPont de Nemours 3Q Cont Ops EPS $1.24 >DD
- DuPont de Nemours 3Q EPS 91c >DD
- Revvity 3Q Net $62.3M >RVTY
- Revvity 3Q EPS 56c >RVTY
- Revvity 3Q Rev $729M >RVTY
- Revvity 3Q Cont Ops EPS 56c >RVTY
- DuPont de Nemours 3Q Net $123M >DD
- Fortis Inc 3Q Adj EPS C$0.92 >FTS
- Waters Corp Sees 4Q Adj EPS $4.58-Adj EPS $4.68 >WAT
- Waters Corp Sees FY Rev $6.48B-$6.5B >WAT
- Waters Corp Sees FY Adj EPS $14.60-Adj EPS $14.70 >WAT
- Nordon Holds Extraordinary Shareholder Meeting
- Waters Corp: Financial Terms of MOBILion Transaction Not Disclosed >WAT
- swissnet Names Stefan Gübeli Group CEO Effective January 1, 2027
- PALANTIR TECHNOLOGIES INC. : MORGAN STANLEY RAISES TARGET PRICE TO $233.00 FROM $205.00
- APPLE, INC. : MORGAN STANLEY CUTS TARGET PRICE TO $350.00 FROM $355.00
- HINGE HEALTH INC <HNGE.N>: MORGAN STANLEY RAISES TARGET PRICE TO $131.00 FROM $117.00
- Remedy Entertainment Q3 EBIT swings to EUR 600,000 profit year on year; Q3 revenue more than triples year on year to EUR 39.6 million
- NEUROCRINE BIOSCIENCES INC <NBIX.O>: MORGAN STANLEY RAISES TARGET PRICE TO $185.00 FROM $183.00
- BIOMARIN PHARMACEUTICAL INC <BMRN.O>: MORGAN STANLEY CUTS TARGET PRICE TO $119.00 FROM $122.00
- Waters acquires MOBILion Systems to expand proteomics capabilities
- ESTEE LAUDER COMPANIES INC <EL.N>: MORGAN STANLEY RAISES TARGET PRICE TO $118.00 FROM $112.00
- -- Earnings Flash (IT) Gartner, Inc. Reports Q3 Revenue $1.50B, vs. FactSet Est of $1.49B
- --GUIDANCE: (DD) DuPont Expects 2026 Adjusted EPS Range $7.47 - $7.52, vs. FactSet Est of $7.26
- -- Earnings Flash (BALL) Ball Corporation Reports Q3 Revenue $4.19B, vs. FactSet Est of $3.78B
- -- Earnings Flash (RVTY) Revvity, Inc. Reports Q3 Revenue $728.9M, vs. FactSet Est of $694.7M
- -- Earnings Flash (LDOS) Leidos Reports Q3 Revenue $4.63B, vs. FactSet Est of $4.71B
- -- Earnings Flash (RVTY) Revvity, Inc. Posts Q3 Adjusted EPS $1.38 per Share, vs. FactSet Est of $1.30
- -- Earnings Flash (FTS) Fortis Posts Q3 Adjusted EPS CA$0.92, vs. FactSet Est of CA$0.88
- -- Earnings Flash (BALL) Ball Corporation Posts Q3 Adjusted EPS $1.10 per Share, vs. FactSet Est of $1.07
- -- Earnings Flash (LDOS) Leidos Posts Q3 Adjusted EPS $3.62 per Share, vs. FactSet Est of $3.03
- --GUIDANCE: (WAT) Waters Expects 2026 Revenue Range $6.48B to $6.50B, vs. FactSet Est of $6.46B
- -- Earnings Flash (ADM) Archer-Daniels-Midland Company Reports Q3 Revenue $22.34B, vs. FactSet Est of $23.27B
- -- GUIDANCE: (DD) DuPont Expects Q4 Revenue $1.82B
- -- Earnings Flash (ADM) Archer-Daniels-Midland Company Posts Q3 Adjusted EPS $1.77 per Share, vs. FactSet Est of $1.60
- -- Earnings Flash (ADM) Archer-Daniels-Midland Company Posts Q3 Adjusted EPS $1.77 per Share, vs. FactSet Est of $1.60
- -- GUIDANCE: (DD) DuPont Expects Q4 Adjusted EPS Range $1.90 - $1.95
- -- Earnings Flash (DD) DuPont Posts Q3 Adjusted EPS $2.09 per Share, vs. FactSet Est of $1.87
- -- Earnings Flash (DD) DuPont Reports Q3 Revenue $1.87B, vs. FactSet Est of $1.84B
- -- Earnings Flash (WAT) Waters Corporation Posts Q3 Adjusted EPS $4.10 per Share, vs. FactSet Est of $4.00
- --GUIDANCE: (WAT) Waters Expects 2026 Adjusted EPS Range $14.60 to $14.70, vs. FactSet Est of $14.59
- -- GUIDANCE: (WAT) Waters Corporation Expects Q4 Adjusted EPS Range $4.58 - $4.68
- -- GUIDANCE: (WAT) Waters Corporation Expects Q4 Revenue Range $1.80B - $1.82B
- -- Earnings Flash (WAT) Waters Corporation Reports Q3 Revenue $1.77B, vs. FactSet Est of $1.75B
